Application YC di Nomic Bio

Winter 2020Active

Nomic Bio ha partecipato a Y Combinator nel batch Winter 2020 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2020
Settore: HealthcareDiagnostics
Dimensione team: 24
Stato: Active
Lanciata: 2020

Founder

Milad DagherFounder
Jeff MunzarFounder

Cosa fa Nomic Bio

Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in top pharmas as well as pioneering biotechs in the space. Our goal is to create a ubiquitous technology that consolidates the broad range of legacy immunoassay toolkits that scientists use today with a single platform that can carry the science end-to-end, from discovery all the way to the clinic. We're a team of engineers, biologists, and highly-skilled lab operators that are looking to grow quickly to keep up with customer demand but also to continue developing our core technology, scale our multiplexing/throughput, and build our software stack. We're hiring on a number of positions including engineering, software, biology, and ops. Come talk to us!

Application YC di Nomic Bio, ricostruita

Domanda per Y Combinator

Nomic Bio, batch Winter 2020. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Nomic Bio

Describe what your company does in 50 characters or less.

Protein profiling like Illumina did for DNA

What is your company going to make? Please describe your product and what it does or will do.

We built the nELISA, a next-generation immunoassay platform that lets drug discovery scientists profile hundreds of proteins simultaneously with 10x higher throughput and 10x lower cost than current solutions. Unlike legacy ELISA kits, our platform scales high-content protein measurement for early discovery through to clinical use, consolidating multiple assay types into one versatile tool.

Where do you live now, and where would the company be based after YC?

We live in Montreal, QC, Canada, and plan to keep the company based here after YC.

Explain your decision regarding location.

Montreal has the local expertise in biochemistry, engineering, and nanotech that our platform requires. It also offers a strong, low-cost talent pool compared to typical US hubs and aligns with the founders' personal ties and initial lab setup.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Nomic Bio?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Nomic Bio (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Nomic Bio si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Nomic Bio?

Nomic Bio apparteneva al batch Winter 2020 di Y Combinator.

Chi ha fondato Nomic Bio?

Nomic Bio è stato fondato da Milad Dagher, Jeff Munzar.

Cosa fa Nomic Bio?

Nomic is doing for proteins what Illumina has done for DNA

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Nomic Bio, e di ogni altro batch YC, è in YC Insights.